Rigel Pharmaceuticals (RIGL) Cash from Operations Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 158.60% |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 405.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 405.15% |
| Dec 31, 2025 | 51.55% |
| Sep 30, 2025 | 10.85% |
| Jun 30, 2025 | 10,011.59% |
| Mar 31, 2025 | 82.19% |
| Dec 31, 2024 | 332.42% |
| Sep 30, 2024 | 1,695.22% |
| Jun 30, 2024 | -94.91% |
| Mar 31, 2024 | -23.05% |
| Dec 31, 2023 | 71.52% |
| Sep 30, 2023 | 89.78% |
| Jun 30, 2023 | 145.93% |
| Mar 31, 2023 | 84.11% |
| Dec 31, 2022 | -14.79% |
| Sep 30, 2022 | -29.17% |
| Jun 30, 2022 | -123.38% |
| Mar 31, 2022 | -28.47% |
| Dec 31, 2021 | -22.57% |
| Sep 30, 2021 | 47.15% |
| Jun 30, 2021 | 493.33% |
| Mar 31, 2021 | -545.17% |
| Dec 31, 2020 | -61.38% |
| Sep 30, 2020 | -33.06% |
| Jun 30, 2020 | 15.69% |
| Mar 31, 2020 | -443.59% |
| Dec 31, 2019 | -182.87% |
| Sep 30, 2019 | 27.09% |
| Jun 30, 2019 | 38.32% |
| Mar 31, 2019 | 97.57% |
| Dec 31, 2018 | 159.06% |
| Sep 30, 2018 | -14.04% |
| Jun 30, 2018 | -38.64% |
| Mar 31, 2018 | -12.68% |
| Dec 31, 2017 | -58.18% |
| Sep 30, 2017 | 21.98% |
| Jun 30, 2017 | -5.62% |
| Mar 31, 2017 | 7.40% |
| Dec 31, 2016 | 9.66% |
| Sep 30, 2016 | -138.67% |
| Jun 30, 2016 | -1.59% |
| Mar 31, 2016 | -224.65% |
| Dec 31, 2015 | 8.04% |
| Sep 30, 2015 | 48.54% |
| Jun 30, 2015 | 9.02% |
| Mar 31, 2015 | 209.49% |
| Dec 31, 2014 | 20.62% |
| Sep 30, 2014 | 11.41% |
| Jun 30, 2014 | 6.46% |
| Mar 31, 2014 | 34.58% |
| Dec 31, 2013 | 12.37% |
| Sep 30, 2013 | -5.70% |
| Jun 30, 2013 | -2.80% |
| Mar 31, 2013 | -7.90% |
| Dec 31, 2012 | -15.64% |
| Sep 30, 2012 | -53.40% |
| Jun 30, 2012 | -20.83% |
| Mar 31, 2012 | -12.09% |
| Dec 31, 2011 | -281.67% |
| Sep 30, 2011 | 32.70% |